BIIB vs NVEC · P/E 21, rev $9.89B vs P/E 35, rev $25.9M
Biogen Inc (BIIB) versus NVE Corporation (NVEC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
NVE Corporation (NVEC) is a semiconductors company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported NVEC revenue for 2025-03-31 was $25.9M. Net income was $15.1M. Revenue was down 13.2% from 2024-03-31 to 2025-03-31. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
Not investment advice. Open the BIIB and NVEC stock pages for the full models.
Not investment advice.